Tech Company Financing Transactions
N-Zyme Biomedical Funding Round
N-Zyme Biomedical secured a $2.8 million investment round on 9/22/2026. Investors included National Institutes of Health.
Transaction Overview
Company Name
Announced On
9/22/2026
Transaction Type
Debt
Amount
$2,760,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding will support both mechanistic research and a Phase II clinical trial without requiring additional equity capital from N-Zyme.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1225 Discovery Parkway 260E
Wauwatosa, WI 53226
USA
Wauwatosa, WI 53226
USA
Phone
Undisclosed
Website
Email Address
Overview
N-Zyme intends to improve the quality of life for millions of people around the globe by developing the first safe, effective and efficient treatments for Laryngopharyngeal Reflux (LPR). N-Zyme Biomedical seeks to provide much-needed treatments for the millions of people in the US and worldwide that suffer from LPR.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Franco Vigile
Chief Scientific Officer
Nikki Johnston
Browse more venture capital transactions:
Prev: 9/21/2026: KTV Working Drone venture capital transaction
Next: 9/22/2026: Blair Health venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs